A

Alliance Pharma PLC
LSE:APH

Watchlist Manager
Alliance Pharma PLC
LSE:APH
Watchlist
Price: 64.5 GBX -0.15% Market Closed
Market Cap: 348.7m GBX

Operating Margin
Alliance Pharma PLC

18.7%
Current
14%
Average
7.1%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
18.7%
=
Operating Profit
33.4m
/
Revenue
178.8m

Operating Margin Across Competitors

Country Company Market Cap Operating
Margin
UK
Alliance Pharma PLC
LSE:APH
348.7m GBP
19%
US
Eli Lilly and Co
NYSE:LLY
831.3B USD
38%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
3%
US
Johnson & Johnson
NYSE:JNJ
373.7B USD
26%
DK
Novo Nordisk A/S
CSE:NOVO B
1.8T DKK
48%
CH
Roche Holding AG
SIX:ROG
210.9B CHF
33%
CH
Novartis AG
SIX:NOVN
189.1B CHF
32%
UK
AstraZeneca PLC
LSE:AZN
163.2B GBP
23%
US
Merck & Co Inc
NYSE:MRK
210.3B USD
35%
IE
Endo International PLC
LSE:0Y5F
163.5B USD
11%
FR
Sanofi SA
PAR:SAN
116.7B EUR
22%

Alliance Pharma PLC
Glance View

Market Cap
348.7m GBX
Industry
Pharmaceuticals

Alliance Pharma Plc is a holding company, which engages in the acquisition, marketing, and distribution of healthcare and pharmaceutical products. The company is headquartered in Chippenham, Wiltshire and currently employs 255 full-time employees. The company went IPO on 2001-11-22. The firm is primarily engaged in the acquisition, marketing and distribution of healthcare and pharmaceutical products. The company is focused on two areas, which include Consumer Healthcare brands and Prescription Medicines. The Company’s Consumer Healthcare brands include Kelo-Cote, Nizoral, Amberen, MacuShield, Vamousse and Aloclair. Its Prescription Medicines include Hydromol, Flamma Franchise and Forceval. Its brands also include Ashton & Parsons and Anbesol. The Company’s products include Alliance Calcium Syrup, Amantadine hydrochloride, Aiweidi, Biodermatin, Biotaches, Buccastem M, Changmin, Decapional, Dermachronic, Dermacide, Dervida, Effadiane, Fazol, Gen-Ongles, Irenat, ISIB, Isocarboxazid, Jonctum, Kelo-Stretch, Lypsyl, Lefuzhi, Malunjunshe, MolluDab, Menadiol, Neostigmine and Nu-Seals. Its geographical area includes Europe, Middle East and Africa (EMEA), Asia Pacific and China (APAC) and Americas (AMER).

APH Intrinsic Value
102.33 GBX
Undervaluation 37%
Intrinsic Value
Price
A
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
18.7%
=
Operating Profit
33.4m
/
Revenue
178.8m
What is the Operating Margin of Alliance Pharma PLC?

Based on Alliance Pharma PLC's most recent financial statements, the company has Operating Margin of 18.7%.

Back to Top